Published in Pharmacopsychiatry on September 01, 2005
Analysis of benzodiazepine withdrawal program managed by primary care nurses in Spain. BMC Res Notes (2012) 0.81
Residential exposure to traffic is associated with coronary atherosclerosis. Circulation (2007) 4.68
Cloning and chromosomal localization of human genes encoding the three chains of type VI collagen. Am J Hum Genet (1988) 2.34
The IMAGEN study: reinforcement-related behaviour in normal brain function and psychopathology. Mol Psychiatry (2010) 2.23
Recombinant nidogen consists of three globular domains and mediates binding of laminin to collagen type IV. EMBO J (1991) 2.23
Biliary adenocarcinoma. Characterisation of three new human tumor cell lines. J Hepatol (1985) 2.18
Characterization of a human osteosarcoma cell line (Saos-2) with osteoblastic properties. Cancer Res (1987) 2.03
Interleukin 5 synthesis by eosinophils: association with granules and immunoglobulin-dependent secretion. J Exp Med (1994) 2.01
Repaglinide in the management of new-onset diabetes mellitus after renal transplantation. Am J Transplant (2006) 2.01
Evidence for simian virus 40 (SV40) coding of SV40 T-antigen and the SV40-specific proteins in HeLa cells infected with nondefective adenovirus type 2-SV40 hybrid viruses. J Virol (1977) 1.94
Structure, function and tissue forms of the C-terminal globular domain of collagen XVIII containing the angiogenesis inhibitor endostatin. EMBO J (1998) 1.91
Role of cysteine residues in regulation of p53 function. Mol Cell Biol (1995) 1.91
Neuroimaging of gender differences in alcohol dependence: are women more vulnerable? Alcohol Clin Exp Res (2005) 1.86
Serotonergic dysfunction, negative mood states, and response to alcohol. Alcohol Clin Exp Res (2001) 1.85
Mip protein of Legionella pneumophila exhibits peptidyl-prolyl-cis/trans isomerase (PPlase) activity. Mol Microbiol (1992) 1.83
Treatment of acromegaly with the GH receptor antagonist pegvisomant in clinical practice: safety and efficacy evaluation from the German Pegvisomant Observational Study. Eur J Endocrinol (2007) 1.83
High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic variables. J Clin Oncol (1996) 1.77
Cell attachment properties of collagen type VI and Arg-Gly-Asp dependent binding to its alpha 2(VI) and alpha 3(VI) chains. Exp Cell Res (1989) 1.77
Characterization of three constituent chains of collagen type VI by peptide sequences and cDNA clones. Eur J Biochem (1987) 1.70
Distinct cytokine patterns in early and chronic ileal lesions of Crohn's disease. Gastroenterology (1997) 1.69
Spontaneous regression of hepatocellular carcinoma. Am J Gastroenterol (1995) 1.68
Formation of stable p53 homotetramers and multiples of tetramers. Mol Carcinog (1992) 1.68
Purification and characterization of perlucin and perlustrin, two new proteins from the shell of the mollusc Haliotis laevigata. Biochem Biophys Res Commun (2000) 1.68
A single EGF-like motif of laminin is responsible for high affinity nidogen binding. EMBO J (1993) 1.62
Genetic association of the human corticotropin releasing hormone receptor 1 (CRHR1) with binge drinking and alcohol intake patterns in two independent samples. Mol Psychiatry (2006) 1.59
Confirmation of the existence of a third family among peptidyl-prolyl cis/trans isomerases. Amino acid sequence and recombinant production of parvulin. FEBS Lett (1994) 1.56
Removal of serine phosphates from simian virus 40 large T antigen increases its ability to stimulate DNA replication in vitro but has no effect on ATPase and DNA binding. J Virol (1987) 1.56
Development of alcohol-associated cues and cue-induced brain activation in alcoholics. Eur Psychiatry (2002) 1.54
Amino acid sequence of the triple-helical domain of human collagen type VI. J Biol Chem (1988) 1.52
Expression and proteolysis of vascular endothelial growth factor is increased in chronic wounds. J Invest Dermatol (2000) 1.51
The thrombomodulin analog Solulin promotes reperfusion and reduces infarct volume in a thrombotic stroke model. J Thromb Haemost (2011) 1.51
Effect of small doses of iodine on thyroid function in patients with Hashimoto's thyroiditis residing in an area of mild iodine deficiency. Eur J Endocrinol (1998) 1.49
Increased epidermal growth factor receptors in gastric carcinomas. Gastroenterology (1990) 1.48
Testicular cancer secretes intact human choriogonadotropin (hCG) and its free beta-subunit: evidence that hCG (+hCG-beta) assays are the most reliable in diagnosis and follow-up. Clin Chem (1990) 1.46
Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes (2006) 1.45
Association of simian virus 40 T antigen with simian virus 40 nucleoprotein complexes. J Virol (1979) 1.43
Strategic planning in medical education: enhancing the learning environment for students in clinical settings. Med Educ (2000) 1.42
Characterization of a type IV collagen major cell binding site with affinity to the alpha 1 beta 1 and the alpha 2 beta 1 integrins. J Cell Biol (1991) 1.41
Does tumor-derived human chorionic gonadotropin act as a thyroid stimulator in vivo? Clin Chem (1993) 1.41
Interaction of p53 with its consensus DNA-binding site. Mol Cell Biol (1995) 1.40
Alcohol-associated stimuli activate the ventral striatum in abstinent alcoholics. J Neural Transm (Vienna) (2001) 1.39
Structure of recombinant N-terminal globule of type VI collagen alpha 3 chain and its binding to heparin and hyaluronan. EMBO J (1992) 1.38
Binding of nidogen and the laminin-nidogen complex to basement membrane collagen type IV. Eur J Biochem (1989) 1.38
ASP-56, a new actin sequestering protein from pig platelets with homology to CAP, an adenylate cyclase-associated protein from yeast. FEBS Lett (1992) 1.37
Impairment of inhibitory control in response to food-associated cues and attentional bias of obese participants and normal-weight controls. Int J Obes (Lond) (2011) 1.37
Observation of five-fold local symmetry in liquid lead. Nature (2000) 1.35
Gene-gene effects on central processing of aversive stimuli. Mol Psychiatry (2007) 1.32
Cartilage oligomeric matrix protein and thrombospondin 1. Purification from articular cartilage, electron microscopic structure, and chondrocyte binding. Eur J Biochem (1994) 1.30
Sequential changes of biochemical bone parameters after kidney transplantation. Nephrol Dial Transplant (1998) 1.29
The neural basis of video gaming. Transl Psychiatry (2011) 1.28
A novel peptidyl-prolyl cis/trans isomerase from Escherichia coli. FEBS Lett (1994) 1.28
Euthyroid and primarily hypothyroid patients develop milder and significantly more asymmetrical Graves ophthalmopathy. Br J Ophthalmol (2009) 1.28
Structural and functional analysis of the recombinant G domain of the laminin alpha4 chain and its proteolytic processing in tissues. J Biol Chem (2000) 1.26
Impact of smoking on the response to treatment of thyroid associated ophthalmopathy. Br J Ophthalmol (2003) 1.25
Posterior retroperitoneoscopy as a new minimally invasive approach for adrenalectomy: results of 30 adrenalectomies in 27 patients. World J Surg (1996) 1.24
Analysis of heparin, alpha-dystroglycan and sulfatide binding to the G domain of the laminin alpha1 chain by site-directed mutagenesis. J Mol Biol (1999) 1.23
The alpha 1 beta 1 integrin recognition site of the basement membrane collagen molecule [alpha 1(IV)]2 alpha 2(IV). EMBO J (1993) 1.23
Recombinant expression and structural and binding properties of alpha 1(VI) and alpha 2(VI) chains of human collagen type VI. Eur J Biochem (1994) 1.23
The fib locus in Streptococcus pneumoniae is required for peptidoglycan crosslinking and PBP-mediated beta-lactam resistance. FEMS Microbiol Lett (2000) 1.21
Short arm region of laminin-5 gamma2 chain: structure, mechanism of processing and binding to heparin and proteins. J Mol Biol (2001) 1.20
Midbrain serotonin transporter binding potential measured with [11C]DASB is affected by serotonin transporter genotype. J Neural Transm (Vienna) (2007) 1.19
Long-term follow-up of thyroid nodule growth. Exp Clin Endocrinol Diabetes (2002) 1.19
Prognostic factors in seminomas with special respect to HCG: results of a prospective multicenter study. Seminoma Study Group. Eur Urol (1999) 1.19
Development and clinical impact of thyroglobulin antibodies in patients with differentiated thyroid carcinoma during the first 3 years after thyroidectomy. Eur J Endocrinol (2005) 1.18
Structural characterization of two variants of fibulin-1 that differ in nidogen affinity. J Mol Biol (1995) 1.18
Relapse prevention by acamprosate. Results from a placebo-controlled study on alcohol dependence. Arch Gen Psychiatry (1996) 1.18
Limited cleavage of extracellular matrix protein BM-40 by matrix metalloproteinases increases its affinity for collagens. J Biol Chem (1997) 1.18
Mapping of nidogen binding sites for collagen type IV, heparan sulfate proteoglycan, and zinc. J Biol Chem (1993) 1.18
Conformational constraints for protein self-cleavage in the proteasome. J Mol Biol (1998) 1.18
Multiple binding of type 3 streptococcal M protein to human fibrinogen, albumin and fibronectin. FEMS Immunol Med Microbiol (1993) 1.17
Excess "read-through" acetylcholinesterase attenuates but the "synaptic" variant intensifies neurodeterioration correlates. Proc Natl Acad Sci U S A (2000) 1.15
Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease. J Clin Endocrinol Metab (1999) 1.15
Characterization of recombinant perlecan domain I and its substitution by glycosaminoglycans and oligosaccharides. Eur J Biochem (1997) 1.15
The N-terminal globular domain of the laminin alpha1 chain binds to alpha1beta1 and alpha2beta1 integrins and to the heparan sulfate-containing domains of perlecan. FEBS Lett (1998) 1.14
Localization of a major nidogen-binding site to domain III of laminin B2 chain. Eur J Biochem (1991) 1.14
Perlustrin, a Haliotis laevigata (abalone) nacre protein, is homologous to the insulin-like growth factor binding protein N-terminal module of vertebrates. Biochem Biophys Res Commun (2001) 1.13
Calcium-dependent binding of basement membrane protein BM-40 (osteonectin, SPARC) to basement membrane collagen type IV. Eur J Biochem (1991) 1.13
High-affinity and low-affinity calcium binding and stability of the multidomain extracellular 40-kDa basement membrane glycoprotein (BM-40/SPARC/osteonectin). Eur J Biochem (1992) 1.12
Cadmium induces conformational modifications of wild-type p53 and suppresses p53 response to DNA damage in cultured cells. J Biol Chem (1999) 1.12
A solid-state NMR, X-ray diffraction, and ab initio computational study of hydrogen-bond structure and dynamics of pyrazole-4-carboxylic acid chains. J Am Chem Soc (2001) 1.11
The nacre protein perlucin nucleates growth of calcium carbonate crystals. J Microsc (2003) 1.11
Bistability of vortex core dynamics in a single perpendicularly magnetized nanodisk. Phys Rev Lett (2009) 1.10
The benefit from whole body acupuncture in major depression. J Affect Disord (2000) 1.10
Activated eosinophils and interleukin 5 expression in early recurrence of Crohn's disease. Gut (1995) 1.09
The disulfide bridge pattern of snake venom disintegrins, flavoridin and echistatin. FEBS Lett (1992) 1.08
Structural models of the bovine papillomavirus E5 protein. Proteins (1998) 1.08
Ovocalyxin-32, a novel chicken eggshell matrix protein. isolation, amino acid sequencing, cloning, and immunocytochemical localization. J Biol Chem (2001) 1.07
[Incidence, clinical picture and treatment of hypothyroid coma. Results of a survey]. Med Klin (Munich) (1997) 1.07
X-ray structure of the quinoprotein ethanol dehydrogenase from Pseudomonas aeruginosa: basis of substrate specificity. J Mol Biol (2000) 1.06
Galantamine reduces smoking in alcohol-dependent patients: a randomized, placebo-controlled trial. Int J Clin Pharmacol Ther (2006) 1.06
Zinc binding and redox control of p53 structure and function. Antioxid Redox Signal (2001) 1.05
Randomised clinical trial: the effect of baclofen in patients with gastro-oesophageal reflux--a randomised prospective study. Aliment Pharmacol Ther (2012) 1.05
Structural properties of recombinant domain III-3 of perlecan containing a globular domain inserted into an epidermal-growth-factor-like motif. Eur J Biochem (1995) 1.05